Evidence map›Paper›PMID 24834381›Full record

ArticleTranslational cancer research2013

Externally modulated theranostic nanoparticles.

Cordula Urban, Alexander S Urban, Heather Charron, Amit Joshi

Abstract read
In one paragraph

Article in Translational cancer research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Nanoparticle-assisted ultrasound: A special focus on sonodynamic therapy against cancer.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2018
    Article
  4. Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?Nanomaterials (Basel, Switzerland) · 2015
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cordula UrbanDepartment of Radiology, Baylor College of Medicine, Houston, TX, USA.
Alexander S UrbanElectrical and Computer Engineering, Rice University, Houston, TX, USA.
Heather CharronDepartment of Radiology, Baylor College of Medicine, Houston, TX, USA.
Amit JoshiDepartment of Radiology, Baylor College of Medicine, Houston, TX, USA.

Funding

Preclinical platform for theranostic nanoparticles in pancreatic cancerU01CA151886 · NCI · RICE UNIVERSITY · PI HALAS, NANCY J · 2010 to 2014
$1.7M
Molecularly guided multimodal theranostics for breast cancerR01CA151962 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI JOSHI, AMIT · 2010 to 2014
$1.5M
NCI NIH HHS R01 CA151962NCI NIH HHS U01 CA151886
6 · The paper itself

Abstract

Externally modulated nanoparticles comprise a rapidly advancing class of cancer nanotherapeutics, which combine the favorable tumor accumulation of nanoparticles, with external spatio-temporal control on therapy delivery via optical, magnetic, or ultrasound modalities. The local control on therapy enables higher tumor treatment efficacy, while simultaneously reducing off-target effects. The nanoparticle interactions with external fields have an additional advantage of frequently generating an imaging signal, and thus such agents provide theranostic (both diagnostic and therapeutic) capabilities. In this review, we classify the emerging externally modulated theranostic nanoparticles according to the mode of external control and describe the physiochemical mechanisms underlying the external control of therapy, and illustrate the major embodiments of nanoparticles in each class with proven biological efficacy: (I) electromagnetic radiation in visible and near-infrared range is being exploited for gold based and carbon nanostructures with tunable surface plasmon resonance (SPR) for imaging and photothermal therapy (PTT) of cancer, photochemistry based manipulations are employed for light sensitive liposomes and porphyrin based nanoparticles; (II) Magnetic field based manipulations are being developed for iron-oxide based nanostructures for magnetic resonance imaging (MRI) and magnetothermal therapy; (III) ultrasound based methods are primarily being employed to increase delivery of conventional drugs and nanotherapeutics to tumor sites.

Indexed as

Cancer nanotechnologygold nanoparticles (AuNPs)hyperthermiaNIR therapytheranostics

Identifiers

PMID24834381
PMCPMC4019206

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.